Ultherapy Evidence for Jowls, Neck and Under Eye in Gangnam, Seoul
UH CELL Clinic Gangnam in Seoul's Gangnam-gu explains what FDA clearance history and published studies cover for Ultherapy PRIME on the jowls, neck and under-eye area, along with the documented safety points to know before treatment.
UH CELL Clinic Gangnam · WD Building 2F-3F, 13 Teheran-ro 8-gil, Gangnam-gu, Seoul · +82-2-6941-0375
UH CELL Clinic Gangnam (UH CELL), located in Gangnam-gu, Seoul, offers Ultherapy PRIME, Ulthera's microfocused ultrasound device, and this page sets out what the FDA clearance record and the published clinical literature actually say about using it on the jowls, neck and under-eye area, together with the safety points patients ask about before booking.
This page answers a treatment-details question: it isn't a sales pitch. We explain which areas the device is cleared for, what a session involves, the result timing described in the literature, and where the published evidence and safety data stop, so you can weigh the jowls, neck and under-eye question for your own situation before you book.
Visiting UH CELL Clinic Gangnam
UH CELL Clinic Gangnam sits at 13 Teheran-ro 8-gil, Gangnam-gu, Seoul, on the 2nd to 3rd floor of the WD Building, a short walk from Gangnam Station, and about 90% of the patients who come through this location travel from Japan, Taiwan, China and English-speaking countries for a stay of 2 to 7 days.
- Address: 13 Teheran-ro 8-gil, Gangnam-gu, Seoul, WD Building 2F-3F, near Gangnam Station
- Hours: Mon, Tue, Wed, Fri 10:00-20:00; Thu, Sat, Sun 10:00-17:00; no lunch break
- Phone: +82-2-6941-0375
- Booking channels: KakaoTalk, LINE, WeChat, WhatsApp, phone
- Languages: interpreter staff for Japanese, Chinese and English consultations
- Nearby hotel recovery care: guests staying at UH FLAT SIGNATURE GANGNAM (11 Teheran-ro 10-gil), the hotel connected with UH CELL, receive one of an oxygen chamber session (30 minutes) or a vitamin IV free of charge after treatment; using both, the vitamin IV is priced at KRW 55,000
Ultherapy PRIME for Jowls and Neck Laxity
Ultherapy PRIME, the UH CELL Clinic Gangnam treatment built on Ulthera's microfocused ultrasound with visualization (MFU-V) device, directs focused ultrasound energy at the SMAS layer to address the submental and neck laxity named in the device's original FDA clearance. Jowls aren't a separate line item on that clearance: jowl improvement is read off the same submental and lower-face laxity indication, so a jowl result from this device rests on the neck and chin clearance. The FDA clearance list has no jowl-specific entry. Change from the heating effect is gradual. The mechanism relies on collagen remodeling that continues for a period after the session, before any lifting becomes visible. UH CELL's own maintenance interval for this treatment is 10 to 12 months. It isn't a shorter cycle.
Session length and the number of lines treated change with the area. They're set after an individual skin analysis, not from one fixed plan for every patient. UH CELL's own procedure page states that patients return to their daily routine immediately after a session, with no listed downtime period. At UH CELL Gangnam, the session takes place in a private treatment room, under the clinic's representative director, Dr. Yeonjin Kim.
Clinical Evidence and FDA Indication
Ultherapy's underlying device holds staged U.S. FDA 510(k) clearances. Each clearance ties to one anatomical claim, not a single face-lifting indication: a 2009 clearance for brow lift, a 2012 clearance for lifting lax tissue of the submental region and neck, and a 2014 clearance for improving lines and wrinkles of the décolletage. The under-eye area doesn't appear on that list. The word "jowls" is language built on the neck and lower-face clearance; it has no regulatory wording of its own.
Independent of the device maker's own marketing pages, published clinical studies on this microfocused ultrasound technology have graded results through standardized photography and blinded-reviewer or physician rating scales, scoring facial and neck laxity before and after a session. The studies don't measure tightening with a lab instrument. Not every treated subject is rated as improved by a blinded reviewer in these studies, and the degree of change reported varies with the treatment site, the energy and depth settings used, and whether the patient had a single session or a series. Studies follow patients over multiple months after a session and grade change at follow-up visits, not right after treatment, consistent with the gradual collagen remodeling described above.
Consumer-facing claims of "lifting" and "tightening" from the device maker sit in a separate category from the blinded-reviewer clinical-trial data described here. Individual results vary because the published evidence itself describes a range of outcomes across study subjects, not one fixed result that applies to every patient.
Under Eye Treatment and Safety Considerations
Ultherapy PRIME applied to the under-eye area is an off-label use at UH CELL and at any clinic offering this device, since the periorbital region sits outside the three documented FDA clearances above. The safety literature on this microfocused ultrasound technology documents transient redness and swelling, bruising, temporary numbness or tingling, and, in rare cases, temporary weakness in a branch of the facial nerve that resolves on its own.
The under-eye area has its own documented caution in that literature. The skin here is thinner, it sits close to the orbital bone and the periorbital fat pad, and off-label treatment there brings a documented risk of contour irregularity or fat volume loss that the submental and neck area doesn't carry in the same way. This is a reason some clinics limit under-eye treatment settings or skip the area altogether, and it's a point worth raising directly in an individual skin analysis before a session.
Counterfeit or refurbished Ultherapy tips have been reported as a market-wide problem in Korea by trade press, which is one reason Korea's distributor runs a tip-certification system across the industry. At UH CELL, devices, injectables and medicines are genuine and are opened in front of the patient before treatment.
Sources: UH CELL's Ultherapy PRIME procedure page, UH CELL's note on interpreter staff for international patients.